We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Imatinib

Australian Public Assessment Report

AusPAR

AusPAR: Imatinib [PDF, 1.01 MB]

AusPAR: Imatinib [Word, 1.86 MB]

Attachment: Product Information: Imatinib [PDF, 714.21 KB]

Attachment: Product Information: Imatinib [Word, 1004.67 KB]

Attachment: Extract from Clinical Evaluation Report: Imatinib [PDF, 1.6 MB]

Attachment 2. Extract from the Clinical Evaluation Report for iamtinib mesylate [Word, 3.19 MB]

Device/Product Name

Glivec

Active ingredients

Imatinib

AusPAR Date

22 January 2014

Published

31 March 2014

Submission Number

PM-2012-02722-3-4

Submission Type

Extension of indications

Decision

Approved